Amanote Research

Amanote Research

    RegisterSign In

Multidrug-Resistant Enterococci Lack CRISPR-cas

mBio - United States
doi 10.1128/mbio.00227-10
Full Text
Open PDF
Abstract

Available in full text

Categories
VirologyMicrobiology
Date

October 12, 2010

Authors
Kelli L. PalmerMichael S. Gilmore
Publisher

American Society for Microbiology


Related search

Recurrence of Multidrug-Resistant Enterococci in a Neutropenic Patient

Cancer Control
MedicineOncologyHematology
1999English

In Vitro Antibacterial Activity of Isopropoxy Benzene Guanidine Against Multidrug-Resistant Enterococci

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Multidrug-Resistant Enterococci in the Hospital Environment: Detection of Novel Vancomycin-Resistant E. Faecium Clone ST910

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2016English

Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus Aureus and Vancomycin-Resistant Enterococci

English

Das CRISPR/Cas-System

Biologie in Unserer Zeit
AgriculturalBiological Sciences
2018English

Crowd-Sourced CRISPR-Cas Responses

Science
MultidisciplinaryPhilosophy of ScienceHistory
2016English

CRISPR-Cas in Streptococcus Pyogenes

RNA Biology
Cell BiologyMolecular Biology
2019English

CRISPR-Cas Systems in Multicellular Cyanobacteria

RNA Biology
Cell BiologyMolecular Biology
2018English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy